CN104327075B - 一种9-氨基取代吡啶并吖啶类衍生物及其制备方法和用途 - Google Patents
一种9-氨基取代吡啶并吖啶类衍生物及其制备方法和用途 Download PDFInfo
- Publication number
- CN104327075B CN104327075B CN201410522422.5A CN201410522422A CN104327075B CN 104327075 B CN104327075 B CN 104327075B CN 201410522422 A CN201410522422 A CN 201410522422A CN 104327075 B CN104327075 B CN 104327075B
- Authority
- CN
- China
- Prior art keywords
- formula
- amino substituted
- acridine
- substituted pyridines
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- PGVGQWZAAZUKEL-CSNJCODYSA-N N=C/C=C\c1cc2nc(cccc3)c3c(NCc3ccccc3)c2cc1 Chemical compound N=C/C=C\c1cc2nc(cccc3)c3c(NCc3ccccc3)c2cc1 PGVGQWZAAZUKEL-CSNJCODYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410522422.5A CN104327075B (zh) | 2014-09-30 | 2014-09-30 | 一种9-氨基取代吡啶并吖啶类衍生物及其制备方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410522422.5A CN104327075B (zh) | 2014-09-30 | 2014-09-30 | 一种9-氨基取代吡啶并吖啶类衍生物及其制备方法和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104327075A CN104327075A (zh) | 2015-02-04 |
CN104327075B true CN104327075B (zh) | 2016-08-24 |
Family
ID=52401894
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410522422.5A Active CN104327075B (zh) | 2014-09-30 | 2014-09-30 | 一种9-氨基取代吡啶并吖啶类衍生物及其制备方法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104327075B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105399671B (zh) * | 2015-12-02 | 2018-04-17 | 广西中医药大学 | 7‑对甲苯氨基苯并[c]吖啶盐酸盐及其制备方法和用途 |
CN105418585A (zh) * | 2015-12-02 | 2016-03-23 | 广西中医药大学 | 7-苯并[c]吖啶(4-对氟苯基)-1,2,3-三唑及其制备方法和用途 |
CN105399726B (zh) * | 2015-12-02 | 2018-04-17 | 广西中医药大学 | 2‑甲基‑9‑吖啶(对甲苯基)‑1,2,3‑三唑及其制备方法和应用 |
CN105418584A (zh) * | 2015-12-02 | 2016-03-23 | 广西中医药大学 | 7-苯并[c]吖啶(4-对甲氧苯基)-1,2,3-三唑及其制备方法和用途 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103254130A (zh) * | 2013-05-09 | 2013-08-21 | 清华大学深圳研究生院 | 吖啶衍生物及其制备方法和用途 |
-
2014
- 2014-09-30 CN CN201410522422.5A patent/CN104327075B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN104327075A (zh) | 2015-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Jiang et al. | Design, synthesis and biological evaluation of new coumarin-dithiocarbamate hybrids as multifunctional agents for the treatment of Alzheimer's disease | |
CN103570727B (zh) | 一种n-苄基色胺酮衍生物及其制备方法和应用 | |
Najafi et al. | Design and synthesis of novel anti-Alzheimer’s agents: Acridine-chromenone and quinoline-chromenone hybrids | |
CN104327075B (zh) | 一种9-氨基取代吡啶并吖啶类衍生物及其制备方法和用途 | |
Ekiz et al. | Synthesis, characterization, and SAR of arylated indenoquinoline‐based cholinesterase and carbonic anhydrase inhibitors | |
CN102532144A (zh) | 一种新型吲哚胺-2,3-双加氧酶抑制剂及其制备方法和用途 | |
Lee et al. | Synthesis of aminoalkyl-substituted aurone derivatives as acetylcholinesterase inhibitors | |
Saeedi et al. | Synthesis and bio-evaluation of new multifunctional methylindolinone-1, 2, 3-triazole hybrids as anti-Alzheimer's agents | |
Karimi Askarani et al. | Design and synthesis of multi-target directed 1, 2, 3-triazole-dimethylaminoacryloyl-chromenone derivatives with potential use in Alzheimer's disease | |
Pouramiri et al. | Synthesis and anticholinesterase activity of new substituted benzo [d] oxazole‐based derivatives | |
Boulebd et al. | Imidazopyranotacrines as Non-Hepatotoxic, Selective Acetylcholinesterase Inhibitors, and Antioxidant Agents for Alzheimer′ s Disease Therapy | |
Sang et al. | Design, synthesis, and biological evaluation of scutellarein carbamate derivatives as potential multifunctional agents for the treatment of Alzheimer's disease | |
CN110143956B (zh) | 他克林-吡啶并噻吩类化合物及其制备方法与用途 | |
Rastegari et al. | Synthesis and evaluation of novel arylisoxazoles linked to tacrine moiety: In vitro and in vivo biological activities against Alzheimer’s disease | |
Zahedi et al. | Dual functional cholinesterase and carbonic anhydrase inhibitors for the treatment of Alzheimer's disease: Design, synthesis, in vitro, and in silico evaluations of coumarin-dihydropyridine derivatives | |
CN101020659B (zh) | 9-胺基烷酰胺基-1-氮杂苯并蒽酮衍生物及其合成方法和应用 | |
Mohammadi‐Khanaposhtani et al. | New 4‐phenylpiperazine‐carbodithioate‐N‐phenylacetamide hybrids: Synthesis, in vitro and in silico evaluations against cholinesterase and α‐glucosidase enzymes | |
Purgatorio et al. | Scouting around 1, 2, 3, 4‐Tetrahydrochromeno [3, 2‐c] pyridin‐10‐ones for Single‐and Multitarget Ligands Directed towards Relevant Alzheimer's Targets | |
Bonacorso et al. | Synthesis, biological evaluation and molecular docking study of 7-amine-spiro [chromeno [4, 3-b] quinoline-6, 1′-cycloalkanes] as new tacrine hybrids | |
CN103864759A (zh) | 他克林-烟酸缀合物、制备方法及其医药用途 | |
CN106588917B (zh) | 咔啉类化合物及其合成方法与抗乙酰胆碱酯酶活性 | |
Raza et al. | Pharmacological Evaluation and Docking Studies of 3‐Thiadiazolyl‐and Thioxo‐1, 2, 4‐triazolylcoumarin Derivatives as Cholinesterase Inhibitors | |
CN108047134A (zh) | 他克林-阿魏酸类化合物及其制备方法与用途 | |
Bathula et al. | Substituted furopyridinediones as novel inhibitors of α-glucosidase | |
CN104854082A (zh) | 3,5,n-三羟基烷酰胺及其衍生物、及其制造方法与用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200414 Address after: 314500 No.1 xc1001-2, Gongnong Road, Nanmen, Chongfu Town, Tongxiang City, Jiaxing City, Zhejiang Province Patentee after: JIAXING JINJING E-COMMERCE Co.,Ltd. Address before: 13 No. 530213 the Guangxi Zhuang Autonomous Region Nanning Qingxiu District five Avenue Patentee before: Guangxi University of Chinese Medicine |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221124 Address after: 200137 Floor 3, No. 665, Zhangjiang Road, China (Shanghai) Pilot Free Trade Zone, Pudong New Area, Shanghai Patentee after: Darui Biomedical Technology (Shanghai) Co.,Ltd. Address before: No.1 xc1001-2, Nanmen Gongnong Road, Chongfu Town, Tongxiang City, Jiaxing City, Zhejiang Province Patentee before: JIAXING JINJING E-COMMERCE Co.,Ltd. |